Drivers and Barriers for the Pharmaceutical Deal Trends in Major Developed Markets

1
Pharmaceutical Deal Trends (2010-2015) and
In-Depth Analysis of Recent Deal Activity
Published on - 1 October, 2015 Number of pages
77 Single User Price 2995
The research methodology used to estimate and
forecast Pharmaceutical Deal TrendsMarket begins
with capturing data on key vendor revenue through
the secondary research.
2
Summary of the Report MIR Researchs latest
report, "Pharmaceutical Deal Trends (20102015)
and In-Depth Analysis of Recent Deal Activity"
discusses deal-making trends for a range of deal
types, such as Mergers Acquisitions (MA) and
strategic alliances. It also examines preference
by deal type, along with disclosed deal values
from 2010 to July 2015, covering start-ups,
mid-level players, and big players. Pharmaceutica
l companies use deal activity to enhance their
research activities, regulatory approach,
geographic presence, commercialization, and
sales. The increasing development of biologics,
especially in oncology, has given a significant
boost to activity in recent years. Analysis
suggests that while the number of deals in 2015
(until July) was lower than the number of deals
in 2014, deal value in 2015 has already exceeded
that of 2014.
3
Looking at the entire period, although strategic
deals were more numerous, MA deals had the
highest deal value. Partnerships were the most
preferred type of deal activity, but saw the
lowest deal value. North America led in terms of
region, followed by Europe and Asia-Pacific. Key
deals covered in this report include the
acquisition of Allergen by Actavis, asset
transactions between Novartis and
GlaxoSmithKline, and the partnership between
Pfizer and Merck.
Click Here To Check Complete Report
4
Scope of the Report

• Which challenges in the pharmaceutical industry
  are encouraging deal activity?
• How important is deal activity to the market?
• Overview of deal activity from 2010 to 2015 -
• What are the trends for MA and strategic deals,
  and what are the key differences between the
  sectors?
• What was the trend for regional involvement in
  each year?
• How do variations in terms of therapy area
  preference affect deal activity?
• Detailed analysis of recent deal activity -
• How do announced and completed deals vary?
• How do deals in 2014 and 2015 compare in terms of
  quarterly volume and value?
• Which regions or therapy areas have encouraged
  recent deal activity?
• Who are the key players?

5

• Complete analysis of recent MA deals -
• How do MA deal types differ in terms of number
  and value?
• Which regions and therapy areas have been
  involved in MA deals since 2013?
• Who are the most important players in MA deals?
• What was the rationale behind key MA deals?
• Complete analysis of recent strategic alliances -
  
• What are the different strategic alliance deal
  types?
• Which key regions and therapy areas have been
  involved in strategic alliances since 2013?
• Which important molecule types and routes of
  administration have recently been involved in
  strategic alliances?
• Who are the key players in strategic alliance
  deals?
• What was the rationale behind key strategic
  alliance deals?

Download Sample Brochure
6
Key Reasons to Buy

• This report will allow you to
• Gain an insight into pharmaceutical deal activity
  via in-depth analysis of the current
  pharmaceutical industry, along with a focus on
  the most lucrative regions and therapy areas for
  both MA and strategic deals
• Examine detailed analysis of key players,
  covering companies involved in MA and strategic
  alliance deals, important deal activity for all
  deal types, and deals involving companies with
  the most numerous and highest-value deals.
• Understand how the current deals market is
  changing, using analysis of deals by molecule
  type, route of administration, and stage of
  development.
• Determine the most appropriate deal activity for
  overcoming challenges and enhancing performance,
  including detailed analysis of the rationale
  behind key recent deals.

Make an Inquiry Before Buying
7
Pharmaceutical Deal Trends (2010-2015) and
In-Depth Analysis of Recent Deal Activity
A detailed qualitative analysis of the factors
responsible to the Pharmaceutical Deal Trends and
future opportunities are provided in the report.
Contact 1-302-684-6088 sales_at_marketintelreports.c
om www.marketintelreports.com
Click here to order a copy of Pharmaceutical Deal
Trends Market Report